Sophiris Bio (SPHS:NASDAQ) soared 27.64% on 2.7 million traded in August’s Stock Challenge. The markets have been on fire in August and the average returns of our members are proof of that.

Sophiris’ shares went vertical Thursday, nine days after reporting its Q2 results.

Randall Woods, president and CEO of Sophiris Bio, commented that,

“2016 is proving to be a transformational year for Sophiris.” He went on to state,“In the past quarter, we completed a Phase 2a proof of concept trial of topsalysin in localized prostate cancer in which topsalysin demonstrated the ability to ablate tumor cells in 50 percent of patients, including two men who experienced complete ablation of their targeted tumor with no evidence of any tumor remaining at 6 months post treatment…”

Click here to read the entire quote and press release.


Two members ride Sophiris higher in August Stock Challenge

Sophiris’ market cap finished the day at approximately $128.5 million. It will have to continue to rally if members ‘Kubota‘ and ‘IraM‘ want a chance of winning August’s Stock Challenge. Both members selected Sophiris for August’s Stock Challenge.

Kubota topped all members Thursday, rising 16.20%.

TSX Venture stocks fought back losses from Wednesday to close up 1.1% to 837.58.

Members ‘wtanchak’ with his 84.01% combined average return and ‘silverandgold’s 80.68% return are leading the month.

View Top 20 Leader Board

Pinnacle Digest, and its employees, are not investment advisors; and any reference to specific securities in the list referred to in this article does not constitute a recommendation thereof. THIS IS NOT INVESTMENT ADVICE. All statements in this article are to be checked and verified by the reader. Readers are encouraged to consult their investment advisors prior to making any investment decisions. The information in this article is of an impersonal nature and should not be construed as individualized advice or investment recommendations.

Pinnacle Digest does not endorse or recommend any of the referenced securities. At the time of publication and distribution of this article (6:00PM PST on August 18, 2016) neither, its employees or consultants owned shares in any of the mentioned companies in this article. This article is intended for informational and entertainment purposes only. The author of this article bears no liability for losses and/or damages arising from the use of this article. This article may contain technical or other inaccuracies, omissions, or typographical errors, for which and its parent company assumes no responsibility. We do not guarantee that any of the companies mentioned in this article or on will perform as we expect, and any comparisons we have made to other companies may not be valid or come into effect.

All statements in this article, other than statements of historical fact, should be considered forward-looking statements. These statements relate to future events or future performance. Much of this article is comprised of statements of projection. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements.